B7H3 targeted CAR-iNKT (Children's National Hospital)

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameB7H3 targeted CAR-iNKT (Children's National Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > NKT cell therapy > Chimeric antigen receptor NKT cell therapy

Mechanisms of ActionAnti-CD276

TargetsCD276 antigen

Therapy Area/IndicationsMedulloblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChildren'S National Hospital

China Registration ClassN/A

Develop Information

Active CompaniesChildren'S National Hospital

Inactive CompaniesN/A

Active IndicationsMedulloblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A